A comprehensive view of Branded Drugs. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Health Care Sector Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Fitch expects US sales of patented drugs to rise 5.3% year-over-year to US$327.3B in 2022, increase to US$371.9B in 2026; patented drug market is over four times the size of generic drug sub-sector, more than 10 times the size of OTC medicine sub-sector

ViiV Healthcare announces FDA approval of Triumeq PD, a dispersible single-tablet treatment regimen for children living with HIV-1

Teva Pharmaceuticals announces settlement agreement with Attorney General of Florida related to opioid-related claims; Teva will pay US$177M over 15 years and will provide lifesaving Narcan nasal spray valued at US$84M over 10 years

AstraZeneca announces approval in Japan for Ondexxya for patients taking Factor Xa inhibitors, which help prevent blood clots but can lead to uncontrolled bleeding; Ondexxya quickly reverses Factor Xa inhibitors in patients experiencing acute bleeding

Takeda announces approval in Japan for TAKHZYRO subcutaneous injection for prevention of acute attacks of hereditary angioedema; condition is a rare genetic disorder that causes recurring swelling

Ask us about our Health Care Sector market view

Trending Chart

Interactive chart with headline count